PAHC
PAHC
NASDAQ · Pharmaceuticals

Phibro Animal Health Corp-A

$34.56
+0.12 (+0.33%)
As of Sep 20, 10:06 PM ET ·
Analyst Consensus
Strong Sell
10
Analysts
Moderate
Coverage
Buy 1 10%
Hold 5 50%
Sell 4 40%
Price Target
Analyst Price Target +211.7% upside
Low Target $71.95
Average Target $107.71
High Target $157.72
Current Price $34.56
Current
$34.56
Target
$107.71
$71.95 $107.71 avg $157.72
Scenario Analysis
Bear Case
$71.95
108.2%
Low target
Base Case
$107.71
+211.7%
Avg target
Bull Case
$157.72
+356.4%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$60.08
-42.5% from high
52-Week Low
$28.25
+22.3% from low
50-Day SMA
$42.00
-17.7% vs SMA
200-Day SMA
$35.40
-2.4% vs SMA
RSI (14)
80.2
Overbought
Target vs 52W High
$107.71
+79.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%